IMMUNOSTIMULATORY COMPOSITIONS

The invention relates to an immunostimulatory composition comprising a liposome-nucleic acid complex wherein said complex contains (1) a liposome which, in terms of its lipids, comprises or consists of a first lipid and a second lipid, wherein the first lipid is a zwitterionic lipid and the second lipid is a cationic lipid, and (2) one or more immunostimulatory oligonucleotides and/or one or more polynucleotides. The invention further relates to certain uses of the immunostimulatory composition and to methods for preparing the same. In particular, the invention concerns the use of a zwitterionic lipid in an immunostimulatory composition comprising a liposome-nucleic acid complex to induce type I interferon immune responses and/or to reduce or even bypass TLR-mediated immune responses..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 29. März Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

PUTZKE SIMONE MARLENE [VerfasserIn]
ILG THOMAS [VerfasserIn]
FELDHUES ELISABETH [VerfasserIn]
HEEP IRIS [VerfasserIn]
LAMPRECHT ALF [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-03-29, Last update posted on www.tib.eu: 2024-01-30, Last updated: 2024-02-02

Patentnummer:

EP4153129

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA017080975